MedPath

Pfizer SA

🇻🇪Venezuela
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

118

Active:54
Completed:56

Trial Phases

2 Phases

Phase 1:36
Not Applicable:64

Drug Approvals

2

NMPA:2

Drug Approvals

Methylprednisolone Sodium Succinate for Injection

Product Name
甲强龙
Approval Number
国药准字HJ20170199
Approval Date
Dec 1, 2021
NMPA

Methylprednisolone Sodium Succinate for Injection

Product Name
甲强龙
Approval Number
国药准字HJ20170197
Approval Date
Aug 18, 2020
NMPA

Clinical Trials

Distribution across different clinical trial phases (100 trials with phase data)• Click on a phase to view related trials

Not Applicable
64 (64.0%)
Phase 1
36 (36.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.